Home / 2012 (page 31)

Yearly Archives: 2012

Fewer Hypo’s with New Degludec Insulin

Insulin degludec, an investigational insulin with a prolonged half-life and a reportedly flatter pharmacokinetic profile with fewer high and low levels, showed a modest hypoglycemic edge over insulin glargine in a 52-week head-to-head comparison in patients with type 2 diabetes….

Read More »

Editor’s Note, DCMS #104:

We are all aware of the problems which can occur when our patients take too much insulin or sulfonylureas, potentially leading to dangerously low blood glucose levels. But can you imagine that a diabetes patient could end up beaten and in jail because of hypoglycemia caused by a non-diabetes medication? …

Read More »

Letter from the Editor #645

This week we have an article in the European Heart Journal that points out having high levels of cardiorespiratory fitness can actually help an obese patient have a lower risk of mortality and cardiovascular events, than individuals who have low cardiovascular fitness and are not obese. These patients often also have …

Read More »

PaQ Insulin Delivery Device

CeQur

  PaQ Insulin Delivery Device   The CeQur device (PaQ), a small discreet, wearable insulin patch infuser, is for continuous subcutaneous delivery. The CeQur insulin infuser includes a disposable insulin reservoir that attaches to a reusable electronic messenger. The device easily attaches to the patient’s abdominal area with a secure adhesive …

Read More »